{"SPADE_UN_11697": {"basic": {"SPADE ID": "SPADE_UN_11697", "Peptide Name": "IN1(designed based on indolicidin and ranalexin)", "Sequence": "LLPWKWPWWKWRR", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.26046345] Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=31.25μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC>250μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;Gram-positive bacteria:Streptococcus pneumoniae(30 clinical isolates)(MIC=31.25–62.5μg/ml), Staphylococcus aureus ATCC 25923(MIC=31.25μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=31.25μg/ml), Enterococcus cloacae(MIC>250μg/ml),", "Linear/Cyclic": "Linear", "Sequence Length": 13}, "extended_data_url": "SPADE_UN_11697_extended.json"}}